Skip to main content

Table 1 Baseline characteristics of all patients and by adverse event grade

From: High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events

 

All

2 or less

n = 49

3 or greater

n = 7

 

n

n

% or

95% CI

n

% or 95% CI

p-value

Clinical characteristics

 Age at start of radiation treatment1

53.4

53.6

49.6–57.8

51.8

40.7–62.9

0.961

 Histology

 

44

89.8

7

100

1.00

  Squamous cell carcinoma

51

 

  Adenocarcinoma

4

4

8.2

0

0

  Adenosquamous

1

1

2.0

0

0

 FIGO stage

 

9

18.4

0

0

0.236

  IB1

9

  IB2

14

13

26.5

1

14.3

  IIA1

0

0

0

0

0

  IIA2

1

1

2.0

0

0

  IIB

16

13

26.5

3

42.9

  IIIA

0

0

0

0

0

  IIIB

15

13

26.5

2

28.6

  IVA

1

0

0

1

14.3

 N stage

 

15

30.6

2

28.6

1.00

  N0

17

  N1 – pelvic nodes

39

34

69.4

5

71.4

 M stage

 

39

79.6

7

100

0.719

  M0

46

  M1 – para-aortic nodes

8

8

16.3

0

  Unknown

2

2

4.1

0

 Clinical tumor size at diagnosis (cm)1

5.4

5.4

4.6 – 6.1

5.5

4.3–6.7

0.742

 ECOG

 

31

63.3

7

100

0.558

  0

38

  1

9

9

18.4

0

0

  2

6

6

12.2

0

0

  3

2

2

4.1

0

0

  4

1

1

2.0

0

0

Treatment characteristics

 Acute toxicity grade

  0

45

45

91.8

0

0

  1

3

3

6.1

0

0

  2

1

1

2.0

0

0

  3

5

0

0

5

71.4

  4

2

0

0

2

28.6

Chronic toxicity grade

0.008

  0

36

35

71.4

1

14.3

  1

5

3

6.1

2

28.6

  2

5

4

8.2

1

14.3

  3

10

7

14.3

3

42.9

  4

0

0

0

0

0

 Treatment Response

0.914

  Stable Disease

5

5

10.2

0

0

  Complete Response

20

18

36.7

2

28.6

  Partial Response

21

19

38.8

3

42.9

  Progression

5

4

8.2

1

14.3

  Unknown

4

3

6.1

1

14.3

 Treatment Duration

     

0.700

  Greater than 56 days

27

23

46.9

4

57.1

  56 days or less

29

26

53.1

3

42.9

 Ovoid Size

0.236

  Large

1

1

2.0

0

0

  Medium

15

15

30.6

0

0

  Mini

8

6

12.2

2

28.6

  Small

30

25

51.0

5

71.4

  Unknown

2

2

4.1

0

0

Comorbidities

 Smoker

 

24

49.0

1

14.3

0.149

  Never

25

  Former

9

8

16.3

1

14.3

  Current

22

17

34.7

5

71.4

 Diabetes Mellitus

 

1.00

  No

50

43

87.8

7

100

  Yes

6

6

12.2

0

0

  1. ECOG Eastern Cooperative Oncology Group Performance Status, FIGO International Federation of Gynecology and Obstetrics
  2. 1Mean